Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

AbbVie Puts Humira on TrumpRx at Steep Discount as Tariff Threat Solidifies

 April 7, 2026

BioSpace

Humira will be available on TrumpRx at an 86% discount, according to media reports, as part of AbbVie’s deal with the White House to avoid tariffs.

Policy / PricingImmunology & InflammationRead full story

Post navigation

Kennedy changes vaccine panel charter after legal setback →
← Gilead strikes again, penning $5bn deal to buy Tubulis

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com